Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Aug 15;172(4):446-52.
doi: 10.1164/rccm.200407-864OC. Epub 2005 May 18.

Genomewide screen for pulmonary function in 200 families ascertained for asthma

Affiliations

Genomewide screen for pulmonary function in 200 families ascertained for asthma

Dirkje S Postma et al. Am J Respir Crit Care Med. .

Abstract

Changes in pulmonary function are important in determining asthma outcome. Genetic factors may influence airway obstruction in asthma. We performed a genomewide screen in 200 families of probands objectively diagnosed with asthma in the 1960s to identify chromosomal regions related to changes in pre- and postbronchodilator lung function (FEV1, VC, and FEV1%VC) and assess influences of early-life smoke exposure. Smoking (pack-years), age, sex, and height were covariates in variance component analyses. Significant evidence for linkage of pre- and postbronchodilator FEV1%VC was obtained for chromosome 2q32 (LOD,4.9, increasing to 6.03 with additional fine-mapping markers, and 3.2, respectively). Linkage existed for chromosome 5q for pre- and postbronchodilator VC (likelihood of disease [LOD], 1.8 and 2.6, respectively). Results for pre- and postbronchodilator FEV1 were less significant (LOD, 1.5 and 1.6, chromosomes 11p and 10q, respectively). Results were not affected by passive smoke exposure. There is significant evidence for linkage of FEV1%VC to chromosome 2q32 in families of probands with asthma, 35 cM proximal from linkage previously observed in families of probands with early-onset chronic obstructive pulmonary disease. Thus, there may be multiple genes on chromosome 2q that are important in determining presence and degree of airflow limitation in families ascertained for obstructive airway disease.

PubMed Disclaimer

Figures

<b>Figure 1.</b>
Figure 1.
Genomewide screen for major genes regulating pre- and postbronchodilator FEV1 and VC values in 200 Dutch families from a proband with asthma. (A) Prebronchodilator FEV1; (B) postbronchodilator FEV1; (C) prebronchodilator VC; (D) postbronchodilator VC.
<b>Figure 1.</b>
Figure 1.
Genomewide screen for major genes regulating pre- and postbronchodilator FEV1 and VC values in 200 Dutch families from a proband with asthma. (A) Prebronchodilator FEV1; (B) postbronchodilator FEV1; (C) prebronchodilator VC; (D) postbronchodilator VC.
<b>Figure 1.</b>
Figure 1.
Genomewide screen for major genes regulating pre- and postbronchodilator FEV1 and VC values in 200 Dutch families from a proband with asthma. (A) Prebronchodilator FEV1; (B) postbronchodilator FEV1; (C) prebronchodilator VC; (D) postbronchodilator VC.
<b>Figure 1.</b>
Figure 1.
Genomewide screen for major genes regulating pre- and postbronchodilator FEV1 and VC values in 200 Dutch families from a proband with asthma. (A) Prebronchodilator FEV1; (B) postbronchodilator FEV1; (C) prebronchodilator VC; (D) postbronchodilator VC.
<b>Figure 2.</b>
Figure 2.
Genomewide screen for major genes regulating pre- and postbronchodilator FEV1%VC values in 200 Dutch families from a proband with asthma. No differences in y-axis scale for pre- and postbronchodilator FEV1%VC. (A) Prebronchodilator FEV1%VC; (B) postbronchodilator FEV1%VC.
<b>Figure 2.</b>
Figure 2.
Genomewide screen for major genes regulating pre- and postbronchodilator FEV1%VC values in 200 Dutch families from a proband with asthma. No differences in y-axis scale for pre- and postbronchodilator FEV1%VC. (A) Prebronchodilator FEV1%VC; (B) postbronchodilator FEV1%VC.

Similar articles

Cited by

References

    1. Koppelman GH, Los H, Postma DS. Genetic and environment in asthma: the answer of twin studies. Eur Respir J 1999;13:2–4. - PubMed
    1. Weiss ST, Tosteson TD, Segal MR, Tager IB, Redline S, Speizer FE. Effects of asthma on pulmonary function in children: a longitudinal population-based study. Am Rev Respir Dis 1992;145:58–64. - PubMed
    1. Vonk JM, Jongepier H, Panhuysen CI, Schouten JP, Bleecker ER, Postma DS. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 2003;58:322–327. - PMC - PubMed
    1. Panhuysen CIM, Bleecker ER, Koeter GH, Meyers DA, Postma DS. Characterization of obstructive airways disease in family members of probands with asthma: an algorithm for the diagnosis of asthma. Am J Respir Crit Care Med 1998;157:1734–1742. - PubMed
    1. GINA guidelines. Available from: www.ginasthma.com [accessed October 2004].

Publication types

Substances